Accenture vs Pfizer: Founders, CEOs and History
Accenture was founded in 1989 by Arthur Andersen Consulting Partners, George Shaheen and is led by Julie Sweet. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.
Company facts
Founders
Accenture
Arthur Andersen Consulting Partners
Accenture has no single founder. It began in the early 1950s as the business and technology consulting practice of Arthur Andersen, the accounting firm founded in 1913.
George Shaheen
George Shaheen led Andersen Consulting from 1989 until September 1999. By the time he left, the consulting unit had about 65,000 staff. In 1997 it began the ICC arbitration to separate from Arthur Andersen.
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
CEOs and their tenures
Accenture
- George Shaheen1989–1999
Managing Partner and CEO, Andersen Consulting
Led Andersen Consulting from its 1989 formation as a separate unit of Andersen Worldwide until September 1999, a period in which the consulting unit grew to about 65,000 employees and began the 1997 ICC arbitration to leave Arthur Andersen.
Source - Joe Forehand1999–2004
CEO
Succeeded Shaheen in November 1999 as global managing partner and CEO. Led the firm through the August 2000 arbitration ruling, the January 1, 2001 rename to Accenture and the July 19, 2001 NYSE IPO at $14.50 per share.
Source - William D. Green2004–2011
CEO
CEO from Sept 1, 2004 to January 2011, after serving as chief operating officer for client services. Revenue was $23.09B in FY2010, his last full fiscal year as CEO.
Source - Pierre Nanterme2011–2019
CEO
CEO from January 2011 and also chairman from February 2013. Revenue grew from $27.35B in FY2011 to $41.60B in FY2018 as originally reported.
Source - David Rowland2019–2019
Interim CEO
Chief financial officer who served as interim CEO from Jan 10, 2019 after Nanterme stepped down, until Julie Sweet took over on Sept 1, 2019.
Source - Julie Sweet2019–present
Chair and CEO
CEO since Sept 1, 2019 and chair since Sept 1, 2021; previously CEO of Accenture North America and, before that, general counsel. Revenue rose from $44.33B in FY2020 to $69.67B in FY2025, and headcount reached about 799,000 by May 31, 2026.
Source
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Timeline: Accenture and Pfizer side by side
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1953Accenture
Arthur Andersen GE feasibility study
Arthur Andersen's administrative services group, led by Joseph Glickauf, carries out a study for General Electric on computerizing payroll at Appliance Park in Louisville, Kentucky.
1989Accenture
Andersen Consulting formed
Arthur Andersen and Andersen Consulting become separate units of Andersen Worldwide Societe Cooperative, with George Shaheen as managing partner and CEO of the consulting unit. The more profitable unit pays the other up to 15% of profits.
1997Accenture
Arbitration with Arthur Andersen begins
Andersen Consulting files an arbitration claim with the International Chamber of Commerce, arguing that Arthur Andersen broke their agreement by building its own competing consulting practice.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
2000Accenture
Arbitration ruling and Avanade
In April 2000 Andersen Consulting and Microsoft form Avanade, a joint venture now majority owned by Accenture.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2001Accenture
Rename to Accenture and NYSE IPO
Andersen Consulting becomes Accenture on Jan 1, 2001, a name based on "Accent on the future" suggested by an employee in Oslo. The Bermuda-incorporated company prices its IPO at $14.50 per share and starts trading on the NYSE on July 19, 2001.
2004Accenture
William D. Green becomes CEO
William D. Green succeeds Joe Forehand as CEO on Sept 1, 2004; Forehand remains chairman.
2009Accenture
Reincorporation in Ireland
On May 26, 2009 the board approves moving the company's place of incorporation from Bermuda to Ireland, which remains its legal domicile.
2011Accenture
Pierre Nanterme becomes CEO
Pierre Nanterme becomes CEO in January 2011. The same year Accenture completes its purchase of insurance software company Duck Creek Technologies.
2013Accenture
Fjord acquisition
Accenture agrees in May 2013 to acquire Fjord, a service design consultancy, adding design capacity to Accenture Interactive.
2016Accenture
Duck Creek stake sold to Apax
Funds advised by Apax Partners buy a 60% stake in Duck Creek Technologies from Accenture, which keeps 40%.
2019Accenture
CEO transition and Droga5
Nanterme steps down for health reasons on Jan 11, 2019 and CFO David Rowland becomes interim CEO. Accenture Interactive completes the purchase of creative agency Droga5, and Julie Sweet becomes CEO on Sept 1, 2019.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2022Accenture
Accenture Song
On April 26, 2022 Accenture Interactive begins going to market as Accenture Song. FY2022 revenue rises 22% to $61.59B.
2023Accenture
$3B Data & AI investment
In June 2023 Accenture announces a $3B investment over three years in its Data & AI practice and a plan to double AI talent to 80,000 people.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2024Accenture
Udacity acquisition
Accenture completes its purchase of online education company Udacity on May 20, 2024 to support its Accenture LearnVantage training business.
2025Accenture
FY2025 results and restructuring
FY2025 revenue reaches $69.67B with $80.62B in new bookings. In September 2025 Accenture outlines a six-month, $865M business optimization program, mainly severance, and moves to a single Reinvention Services unit.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2026Accenture
Faculty and Ookla deals
Accenture completes the acquisition of UK AI company Faculty on March 16, 2026 and agrees in March 2026 to buy Ziff Davis's connectivity division (Ookla, Speedtest, Downdetector) for $1.2B in cash. Q3 FY2026 revenue is $18.72B.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
Acquisitions
Accenture
- Faculty2026Undisclosed
- Ookla (Ziff Davis Connectivity division)2026$1.2B
- Udacity2024Undisclosed
- umlaut2021Undisclosed
- Droga52019Undisclosed
- Fjord2013Undisclosed
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Questions about Accenture vs Pfizer
Who is the CEO of Accenture PLC and Pfizer Inc.?
Accenture PLC is led by Julie Sweet and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Accenture PLC founded vs Pfizer Inc.?
Pfizer Inc. was founded in 1849 — 140 years before Accenture PLC, which was founded in 1989. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Accenture PLC.
How many employees does Accenture PLC have compared to Pfizer Inc.?
Accenture PLC employs approximately 799,000 people, while Pfizer Inc. employs approximately 75,000. Accenture PLC has the larger workforce at 799,000 employees, compared to Pfizer Inc.'s 75,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Accenture PLC and Pfizer Inc. headquartered?
Accenture PLC is headquartered in Ireland and Pfizer Inc. is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Accenture PLC and Pfizer Inc.?
Accenture PLC was founded by Arthur Andersen Consulting Partners, George Shaheen. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.
Which company has a longer operating history — Accenture PLC or Pfizer Inc.?
Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. Accenture PLC has been in operation for around 37 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Accenture vs Pfizer overview